Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
106.40    -0.30 (-0.28%)
Bid:
106.10
Ask:
106.40
Spread: 0.30 (0.283%)
Market Cap: £331.29m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

EPT Disclosure

4 Sep 2008 11:12

RNS Number : 7320C
Credit Suisse Securities (Eur) Ltd
04 September 2008
 

FORM 38.5 (b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION 

Name of exempt principal trader

Credit Suisse Securities (Europe) Limited

 

Company dealt in

Michael Page International Plc

 

Class of relevant security to which the dealings being disclosed relate (Note 1)

 

Ordinary Shares

Date of dealing

03-Sep-2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

71312

0.022

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell 

 

 

 

 

Total

 

 

71312

0.022

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 

Class Of Relevant Security : 

Long

Short

(1) Relevant Securities 

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchasesell 

 

 

Total

 

 

(c) Rights to subscribe (Note 2) 

Class of relevant security:

Details

 

 

3. DEALINGS (Note 3)

(a) Purchases and sales 

Purchase/sale

Number of securities

Price per unit (Note 4)

Buy

5251

3.535 (GBP)

Buy

4316

3.4925 (GBP)

Buy

3624

3.5225 (GBP)

Buy

2602

3.5225 (GBP)

Buy

2602

3.5225 (GBP)

Buy

2358

3.5 (GBP)

Buy

2293

3.5225 (GBP)

Buy

2292

3.5225 (GBP)

Buy

2166

3.51 (GBP)

Buy

2117

3.5475 (GBP)

Buy

2068

3.5225 (GBP)

Buy

1885

3.52 (GBP)

Buy

1706

3.5325 (GBP)

Buy

1384

3.5475 (GBP)

Buy

1326

3.5275 (GBP)

Buy

1112

3.5 (GBP)

Buy

1085

3.5475 (GBP)

Buy

1083

3.5 (GBP)

Buy

1067

3.5375 (GBP)

Buy

1059

3.5 (GBP)

Buy

919

3.5 (GBP)

Buy

788

3.535 (GBP)

Buy

701

3.5 (GBP)

Buy

694

3.55 (GBP)

Buy

689

3.5025 (GBP)

Buy

684

3.495 (GBP)

Buy

674

3.5 (GBP)

Buy

560

3.5675 (GBP)

Buy

500

3.5375 (GBP)

Buy

441

3.5075 (GBP)

Buy

391

3.5 (GBP)

Buy

300

3.515 (GBP)

Buy

300

3.535 (GBP)

Buy

300

3.5675 (GBP)

Buy

219

3.5375 (GBP)

Buy

175

3.5 (GBP)

Buy

167

3.5025 (GBP)

Buy

154

3.5675 (GBP)

Sell

4003

3.5125 (GBP)

Sell

3972

3.4925 (GBP)

Sell

3200

3.4925 (GBP)

Sell

3022

3.4975 (GBP)

Sell

2583

3.505 (GBP)

Sell

2257

3.5275 (GBP)

Sell

1300

3.4975 (GBP)

Sell

1300

3.53 (GBP)

Sell

1201

3.52 (GBP)

Sell

1196

3.4925 (GBP)

Sell

1174

3.4975 (GBP)

Sell

1000

3.495 (GBP)

Sell

1000

3.495 (GBP)

Sell

964

3.4975 (GBP)

Sell

939

3.56 (GBP)

Sell

861

3.4975 (GBP)

Sell

711

3.515 (GBP)

Sell

660

3.535 (GBP)

Sell

593

3.4925 (GBP)

Sell

587

3.4975 (GBP)

Sell

566

3.53 (GBP)

Sell

519

3.495 (GBP)

Sell

500

3.5325 (GBP)

Sell

500

3.4975 (GBP)

Sell

500

3.5175 (GBP)

Sell

500

3.53 (GBP)

Sell

488

3.505 (GBP)

Sell

479

3.5125 (GBP)

Sell

342

3.5425 (GBP)

Sell

270

3.535 (GBP)

Sell

200

3.5325 (GBP)

Sell

174

3.5375 (GBP)

Sell

172

3.55 (GBP)

Sell

116

3.515 (GBP)

Sell

116

3.5325 (GBP)

Sell

96

3.5375 (GBP)

Sell

79

3.5125 (GBP)

Sell

68

3.4925 (GBP)

Total Buys: 52,052

Total Sells: 38,208

(b) Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

 

 

 

(c) Options transactions in respect of existing securities 

(i) Writing, selling, purchasing or varying 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

(ii) Exercising 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

(d) Other dealings (including new securities) (Note 3) 

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

 

 

 

4. OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8)  No

Date of disclosure

 04-09-2008

 

Contact name

 Simon Crawley/ Carolyn Collins

 

Telephone number

 020 7888 5416

 

Name of offeree/offeror with which connected

Adecco

 

Nature of connection (Note 9)

ADVISOR

Notes 

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSSFFSLSASEFU
Date   Source Headline
30th Mar 20105:59 pmRNSDirector/PDMR Shareholding
30th Mar 20109:39 amRNSNotice of Results
29th Mar 20105:25 pmRNSDirector/PDMR Shareholding
29th Mar 20102:27 pmRNSDoc re. Purchase of Shares in a Close Period
29th Mar 20101:07 pmRNSHolding(s) in Company
26th Mar 20105:29 pmRNSDirector/PDMR Shareholding
25th Mar 20105:46 pmRNSDirector/PDMR Shareholding
24th Mar 20105:25 pmRNSDirector/PDMR Shareholding
23rd Mar 20105:46 pmRNSDirector/PDMR Shareholding
23rd Mar 201011:05 amRNSDirector/PDMR Shareholding
22nd Mar 20109:44 amRNSDirector/PDMR Shareholding
19th Mar 201010:42 amRNSDirector/PDMR Shareholding
18th Mar 201010:13 amRNSDirector/PDMR Shareholding
17th Mar 201012:40 pmRNSDirector/PDMR Shareholding
16th Mar 20105:46 pmRNSHolding(s) in Company
16th Mar 20103:49 pmRNSDirector/PDMR Shareholding
10th Mar 20103:40 pmRNSDirector/PDMR Shareholding
10th Mar 20102:34 pmRNSDirector/PDMR Shareholding
5th Mar 201010:53 amRNSFinal Dividend - Date Amendment
5th Mar 20107:00 amRNSFinal Results
26th Feb 20102:49 pmRNSTotal Voting Rights
22nd Feb 20101:51 pmRNSNotice of Full Year Results
1st Feb 20103:03 pmRNSTotal Voting Rights
8th Jan 20107:00 amRNSTrading Statement
4th Jan 201010:10 amRNSNotice of Q4 2009 Trading Update
31st Dec 200911:57 amRNSTotal Voting Rights
24th Dec 20097:01 amRNSPurchase of Shares in Close Period
14th Dec 200911:40 amRNSBlocklisting Interim Review
30th Nov 20093:36 pmRNSTotal Voting Rights
11th Nov 20093:37 pmRNSHolding(s) in Company
2nd Nov 200911:05 amRNSTotal Voting Rights
14th Oct 20094:58 pmRNSDirector/PDMR Shareholding
7th Oct 20097:00 amRNSQ3 2009 Trading Update
30th Sep 200912:17 pmRNSTotal Voting Rights
28th Sep 20094:55 pmRNSDoc re. Half Yearly Financial Report
28th Sep 200910:38 amRNSThird Quarter Interim Management Statement
22nd Sep 20093:26 pmRNSHolding(s) in Company
22nd Sep 20092:55 pmRNSHolding(s) in Company
1st Sep 20094:45 pmRNSTotal Voting Rights
17th Aug 20097:00 amRNSHalf Year Results
10th Aug 20094:19 pmRNSNotice of Results
10th Aug 200912:36 pmRNSHolding(s) in Company
31st Jul 20095:12 pmRNSTotal Voting Rights
7th Jul 20097:00 amRNSQ2 and First Half 2009 Trading Update
2nd Jul 20099:29 amRNSNotice of Second Quarter 2009 Trading Update
1st Jul 20099:11 amRNSTotal Voting Rights
22nd Jun 200911:58 amRNSHolding(s) in Company
17th Jun 20093:47 pmRNSHolding(s) in Company
16th Jun 20095:22 pmRNSRefund of Overpaid VAT
12th Jun 20094:58 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.